DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis

Mara Oliveri, Antonio Daga, Claudia Cantoni, Claudio Lunardi, Romano Millo, Antonio Puccetti

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Internucleosomal DNA fragmentation following the activation of endonucleases is the common end point of apoptosis. DNase I, a Ca 2+/Mg 2+-dependent endonuclease ubiquitously expressed in mammalian tissues, is believed to play a role in this process. To analyze the in vivo function of this enzyme in human cells, we have generated a cell line with targeted disruption of the DNase I gene, as well as several stable cell lines which overexpress the DNase I gene. Inactivation of the human DNase I gene was obtained in the Jurkat T cell clone JA3, characterized by high susceptibility to apoptotic cell death induced by pharmacological stimuli. JA3 cells, after disruption of the DNase I gene, became resistant to apoptotic stimuli. DNase I was overexpressed in the human cell lines JA3, K562 (erythroleukemia), M 14 (melanoma) and CEM (T cell lymphoma). Remarkably, stable overexpression of DNase I gene resulted in accelerated apoptosis in JA3 cells and induced apoptosis in K562, CEM and M14 cell lines, which are otherwise resistant to internucleosomal DNA degradation following pharmacological stimuli. Our study provides the first in vivo evidence that DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis.

Original languageEnglish
Pages (from-to)743-751
Number of pages9
JournalEuropean Journal of Immunology
Volume31
Issue number3
DOIs
Publication statusPublished - 2001

Fingerprint

Deoxyribonuclease I
Apoptosis
DNA
Pharmaceutical Preparations
Cell Line
Genes
Endonucleases
Pharmacology
Leukemia, Erythroblastic, Acute
Jurkat Cells
T-Cell Lymphoma
DNA Fragmentation
Melanoma
Cell Death
Clone Cells
T-Lymphocytes
Enzymes

Keywords

  • Chemotherapy
  • DNA fragmentation
  • DNase I
  • Gene targeting

ASJC Scopus subject areas

  • Immunology

Cite this

DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis. / Oliveri, Mara; Daga, Antonio; Cantoni, Claudia; Lunardi, Claudio; Millo, Romano; Puccetti, Antonio.

In: European Journal of Immunology, Vol. 31, No. 3, 2001, p. 743-751.

Research output: Contribution to journalArticle

Oliveri, Mara ; Daga, Antonio ; Cantoni, Claudia ; Lunardi, Claudio ; Millo, Romano ; Puccetti, Antonio. / DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis. In: European Journal of Immunology. 2001 ; Vol. 31, No. 3. pp. 743-751.
@article{42b4ef51672a4990a689e2df22f88552,
title = "DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis",
abstract = "Internucleosomal DNA fragmentation following the activation of endonucleases is the common end point of apoptosis. DNase I, a Ca 2+/Mg 2+-dependent endonuclease ubiquitously expressed in mammalian tissues, is believed to play a role in this process. To analyze the in vivo function of this enzyme in human cells, we have generated a cell line with targeted disruption of the DNase I gene, as well as several stable cell lines which overexpress the DNase I gene. Inactivation of the human DNase I gene was obtained in the Jurkat T cell clone JA3, characterized by high susceptibility to apoptotic cell death induced by pharmacological stimuli. JA3 cells, after disruption of the DNase I gene, became resistant to apoptotic stimuli. DNase I was overexpressed in the human cell lines JA3, K562 (erythroleukemia), M 14 (melanoma) and CEM (T cell lymphoma). Remarkably, stable overexpression of DNase I gene resulted in accelerated apoptosis in JA3 cells and induced apoptosis in K562, CEM and M14 cell lines, which are otherwise resistant to internucleosomal DNA degradation following pharmacological stimuli. Our study provides the first in vivo evidence that DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis.",
keywords = "Chemotherapy, DNA fragmentation, DNase I, Gene targeting",
author = "Mara Oliveri and Antonio Daga and Claudia Cantoni and Claudio Lunardi and Romano Millo and Antonio Puccetti",
year = "2001",
doi = "10.1002/1521-4141(200103)31:3<743::AID-IMMU743>3.0.CO;2-9",
language = "English",
volume = "31",
pages = "743--751",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "wiley",
number = "3",

}

TY - JOUR

T1 - DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis

AU - Oliveri, Mara

AU - Daga, Antonio

AU - Cantoni, Claudia

AU - Lunardi, Claudio

AU - Millo, Romano

AU - Puccetti, Antonio

PY - 2001

Y1 - 2001

N2 - Internucleosomal DNA fragmentation following the activation of endonucleases is the common end point of apoptosis. DNase I, a Ca 2+/Mg 2+-dependent endonuclease ubiquitously expressed in mammalian tissues, is believed to play a role in this process. To analyze the in vivo function of this enzyme in human cells, we have generated a cell line with targeted disruption of the DNase I gene, as well as several stable cell lines which overexpress the DNase I gene. Inactivation of the human DNase I gene was obtained in the Jurkat T cell clone JA3, characterized by high susceptibility to apoptotic cell death induced by pharmacological stimuli. JA3 cells, after disruption of the DNase I gene, became resistant to apoptotic stimuli. DNase I was overexpressed in the human cell lines JA3, K562 (erythroleukemia), M 14 (melanoma) and CEM (T cell lymphoma). Remarkably, stable overexpression of DNase I gene resulted in accelerated apoptosis in JA3 cells and induced apoptosis in K562, CEM and M14 cell lines, which are otherwise resistant to internucleosomal DNA degradation following pharmacological stimuli. Our study provides the first in vivo evidence that DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis.

AB - Internucleosomal DNA fragmentation following the activation of endonucleases is the common end point of apoptosis. DNase I, a Ca 2+/Mg 2+-dependent endonuclease ubiquitously expressed in mammalian tissues, is believed to play a role in this process. To analyze the in vivo function of this enzyme in human cells, we have generated a cell line with targeted disruption of the DNase I gene, as well as several stable cell lines which overexpress the DNase I gene. Inactivation of the human DNase I gene was obtained in the Jurkat T cell clone JA3, characterized by high susceptibility to apoptotic cell death induced by pharmacological stimuli. JA3 cells, after disruption of the DNase I gene, became resistant to apoptotic stimuli. DNase I was overexpressed in the human cell lines JA3, K562 (erythroleukemia), M 14 (melanoma) and CEM (T cell lymphoma). Remarkably, stable overexpression of DNase I gene resulted in accelerated apoptosis in JA3 cells and induced apoptosis in K562, CEM and M14 cell lines, which are otherwise resistant to internucleosomal DNA degradation following pharmacological stimuli. Our study provides the first in vivo evidence that DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis.

KW - Chemotherapy

KW - DNA fragmentation

KW - DNase I

KW - Gene targeting

UR - http://www.scopus.com/inward/record.url?scp=0035081830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035081830&partnerID=8YFLogxK

U2 - 10.1002/1521-4141(200103)31:3<743::AID-IMMU743>3.0.CO;2-9

DO - 10.1002/1521-4141(200103)31:3<743::AID-IMMU743>3.0.CO;2-9

M3 - Article

VL - 31

SP - 743

EP - 751

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 3

ER -